AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (4.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study

Lunan Qi1,2,3,* ( )Jingxuan Xu1,3,*Yuanyuan Chen3,4Zhan Lu1,3,5Min Zhou3,6Yingwu Huang7Yongchi Ling8Hai Huang9Yuchong Peng10Tao Peng2,3,11Bangde Xiang1,2,3Liang Ma1,2,3 ( )
Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning 530021, China
Guangxi Liver Cancer Diagnosis and Treatment Engineering and Technology Research Center, Nanning 530021, China
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning 530021, China
Department of Ultrasound, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China
Department of Hepatobiliary Surgery, Guangxi International Zhuang Medical Hospital, Nanning 530021, China
Department of General Surgery, Liuzhou Workers’ Hospital, Liuzhou 545005, China
Department of Hepatobiliary Surgery, Chongzuo People’s Hospital, Chongzuo 532200, China
Department of Surgery, Fusui County People’s Hospital of Guangxi, Fusui 543200, China
Department of Hepatobiliary Surgery, Wuming Hospital of Guangxi Medical University, Wuming 530100, China
Department of General Surgery, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400021, China
Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China

*These authors contributed equally to this work.

Show Author Information

Abstract

Objective

Hyper-progression recurrence (HPR) after hepatectomy is a specific recurrence pattern associated with extremely poor prognosis in patients with hepatocellular carcinoma (HCC). This study was aimed at investigating the probable risk factors and establishing comprehensive models for formulating clinical strategies.

Methods

Overall, 16,158 patients with HCC from 8 hospitals were screened, among whom 3,125 patients who underwent R0 resection were included, and divided into development (n = 2,113) and validation (n = 1,012) cohorts. A comprehensive study of HPR predictive models and biological features was conducted.

Results

Among the 3,125 enrolled patients, 506 (16.19%) developed HPR. The influence of HPR on extremely poor prognosis was reflected by recurrence features, adverse effects on systemic and liver function, and limited therapeutic options. Nine variables closely associated with HPR were identified, and incorporated into nomogram and conditional inference tree models, which successfully achieved pre- and post-operative HPR risk stratification and facilitated clinical decision-making. Multi-dimensional verification also confirmed the predictive accuracy of model combinations and their reliability in clinical applications. Furthermore, biological analyses revealed that HCCs with HPR exhibited hyperactive biological processes, inactive metabolism, and immune exhaustion features, together with high MYCN/HMGA2 co-expression, thereby enhancing understanding of the molecular events leading to HPR and providing valuable knowledge for HPR management.

Conclusions

HPR after hepatectomy is associated with extremely poor prognosis and requires substantial attention. We constructed comprehensive predictive models and propose a clinical strategy for guiding HPR prevention and management.

Electronic Supplementary Material

Download File(s)
cbm-22-8-964_ESM.pdf (1.7 MB)

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 964-987

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Qi L, Xu J, Chen Y, et al. Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study. Cancer Biology & Medicine, 2025, 22(8): 964-987. https://doi.org/10.20892/j.issn.2095-3941.2024.0514

688

Views

33

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 14 November 2024
Accepted: 15 April 2025
Published: 11 July 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License